Cell-based Strategies in Cancer Research
Translational approaches from Biology to Mechanisms
Cell-based strategies are revolutionizing cancer research, offering precise and personalized approaches to target tumors. In this session, we’ll explore how flow cytometry represents a pivotal tool to develop cell-based strategies to accelerate CAR-T and engineered MSCs research.
Join Dr. Giulia Grisendi as she dives into how advanced flow cytometry acts as the bridge between basic research and translational breakthroughs. We will explore the development of engineered Mesenchymal Stromal/Stem Cells (MSCs) and the cutting edge of CAR-T research.
What you will learn:
Innovative Workflows: Discover how flow cytometry drives the next generation of cell-based cancer strategies.
Multimodality Approach: Understand the power of integrating cytometric and functional data to accelerate your understanding of cellular mechanisms.
Speaker
Dr. Giulia Grisendi
Group Leader, Cell Therapy Unit
University of Modena and Reggio Emilia (UniMORE)
Dr. Grisendi is a leading researcher specializing in translational cell and gene therapy. As the Principal Investigator of the Cell Analyses Unit, she leads advanced functional studies to decode the mechanisms of cancer and immunology, with a specific focus on engineered MSCs and CAR-Ts.
Cell-based Strategies in Cancer Research Translational approaches from Biology to MechanismsCell-based Strategies in Cancer Research
A webinar focused on innovative cell-based strategies for cancer research, highlighting the use of engineered mesenchymal stromal cells and CAR T cells, with flow cytometry as a central tool for characterization, functional assays, and tumor targeting.
